يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Kari Wisinski"', وقت الاستعلام: 0.31s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
  4. 4
  5. 5
    Report

    المساهمون: Kari Wisinski, Sponsor Investigator

    المصدر: A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024

  6. 6
    Report

    المؤلفون: Pfizer, Celcuity Inc

    المساهمون: Kari Wisinski, Faculty, University of Wisconsin School of Medicine and Public Health

    المصدر: Phase 2 Trial With Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers Big Ten Cancer Research Consortium BTCRC-BRE18-337